Factors causing dose variability in drug administration

Romano Demicheli; Antonio Jirillo; Giorgio Bonciarelli; Federico Lonardi; Marco Pradella; Mario Balli

doi:10.1007/bf00257443

Factors causing dose variability in drug administration

Cancer Chemotherapy and Pharmacology ◽

10.1007/bf00257443 ◽

1989 ◽

Vol 24 (6) ◽

Author(s):

Romano Demicheli ◽

Antonio Jirillo ◽

Giorgio Bonciarelli ◽

Federico Lonardi ◽

Marco Pradella ◽

...

Keyword(s):

Drug Administration ◽

Dose Variability

Download Full-text

992: Verapamil Versus Saline in Electromotive Drug Administration (EMDA) for Peyronie's Disease: A Double-Blind Placebo-Controlled Trial

The Journal of Urology ◽

10.1016/s0022-5347(18)33217-8 ◽

2006 ◽

Vol 175 (4S) ◽

pp. 320-320

Author(s):

Jason M. Greenfield ◽

Sneha J. Shah ◽

Laurence A. Levine

Keyword(s):

Drug Administration ◽

Controlled Trial ◽

Peyronie’S Disease ◽

Double Blind ◽

Double Blind Placebo ◽

Peyronie's Disease ◽

Electromotive Drug Administration

Download Full-text

"The loaves and the fishes": A comment on "The emperor's new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration."

Prevention & Treatment ◽

10.1037/1522-3736.5.1.529c ◽

2002 ◽

Vol 5 (1) ◽

Author(s):

Daniel E. Moerman

Keyword(s):

Drug Administration ◽

Food And Drug Administration ◽

Antidepressant Medication ◽

New Drugs ◽

The U.S

Download Full-text

FDA Approves Non-Stimulant ADHD Drug The Food and Drug Administration has approved - Strattera, (atomoxetine)

PsycEXTRA Dataset ◽

10.1037/e300882003-001 ◽

2002 ◽

Author(s):

Keyword(s):

Drug Administration ◽

Food And Drug Administration

Download Full-text

Customer satisfaction results for the Food and Drug Administration Announced.

PsycEXTRA Dataset ◽

10.1037/e311812004-001 ◽

1999 ◽

Cited By ~ 1

Author(s):

Keyword(s):

Customer Satisfaction ◽

Drug Administration ◽

Food And Drug Administration

Download Full-text

Statement by Robert J. Temple, M.D.: Associate Director for Center for Drug Evaluation and Research: Food and Drug Administration: Before the Committee on Government Reform, U.S. House of Representatives

PsycEXTRA Dataset ◽

10.1037/e314462004-001 ◽

2001 ◽

Cited By ~ 1

Author(s):

Robert Temple

Keyword(s):

Drug Administration ◽

House Of Representatives ◽

Drug Evaluation ◽

Food And Drug Administration ◽

Government Reform ◽

Associate Director

Download Full-text

Statement of John M. Taylor, Association Commissioner for Regulatory Affairs, U.S. Food and Drug Administration: Before the Committee on Health, Education, Labor and Pensions, United States Senate: May 20, 2004

PsycEXTRA Dataset ◽

10.1037/e375302004-001 ◽

2004 ◽

Author(s):

Keyword(s):

United States ◽

Health Education ◽

Drug Administration ◽

Food And Drug Administration ◽

United States Senate ◽

Regulatory Affairs

Download Full-text

Glucose tolerance in dogs exposed to altitude and drug administration: Amphetamine

PsycEXTRA Dataset ◽

10.1037/e534142008-001 ◽

1968 ◽

Author(s):

Martin Taub ◽

Albert T. Bernardini

Keyword(s):

Glucose Tolerance ◽

Drug Administration

Download Full-text

Statement By Jane E. Henney, M.D. Commissioner of Food And Drugs Food And Drug Administration: Before The Committee on Health, Education, Labor And Pensions United States Senate Hearing on E-Drugs

PsycEXTRA Dataset ◽

10.1037/e616092007-001 ◽

2000 ◽

Author(s):

Jane E. Henney

Keyword(s):

United States ◽

Health Education ◽

Drug Administration ◽

Food And Drug Administration ◽

United States Senate

Download Full-text

Enrollment of Elderly Patients in Clinical Trials for Cancer Drug Registration: A 7-Year Experience by the US Food and Drug Administration

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70434-6 ◽

2006 ◽

Vol 2006 ◽

pp. 193-194

Author(s):

P.J. Loehrer

Keyword(s):

Clinical Trials ◽

Elderly Patients ◽

Drug Administration ◽

Food And Drug Administration ◽

Cancer Drug ◽

Drug Registration ◽

The Us

Download Full-text

A Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemption Study of Lumbar Total Disc Replacement With the CHARITÉ™ Artifiical Disc Versus Lumbar Fusion: Part II: Evaluation of Radiographic Outcomes and Correlation of Surgical Technique Accuracy With Clinical Outcomes

Yearbook of Orthopedics ◽

10.1016/s0276-1092(08)70536-4 ◽

2006 ◽

Vol 2006 ◽

pp. 260-261 ◽

Cited By ~ 1

Author(s):

M.J. Yaszemski

Keyword(s):

Surgical Technique ◽

Clinical Outcomes ◽

Drug Administration ◽

Lumbar Fusion ◽

Food And Drug Administration ◽

Total Disc Replacement ◽

Disc Replacement ◽

Lumbar Total Disc Replacement ◽

Radiographic Outcomes ◽

Investigational Device Exemption

Download Full-text